Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 1, 2004, Pages 193-198

  Lanao, José M ^a   Calvo, Ma Victoria ^b   Mesa, José Antonio ^b   Martín Suárez, Ana ^a   Carbajosa, Ma Teresa ^a   Miguelez, Francisco ^a   Domínguez Gil, Alfonso ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Aminoglycosides; Extended interval dosage regimens; Population pharmacokinetics

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN;

ARTICLE; BODY WEIGHT; COMPARTMENT MODEL; CONTROLLED STUDY; COVARIANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG HALF LIFE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; NEWBORN; NEWBORN INFECTION; NONLINEAR SYSTEM; PERINATAL PERIOD; POPULATION MODEL; PREMATURITY; RETROSPECTIVE STUDY; SIMULATION; VALIDATION PROCESS; VERY LOW BIRTH WEIGHT;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BAYES THEOREM; BIRTH WEIGHT; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HALF-LIFE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MODELS, BIOLOGICAL; POPULATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 3543075756     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh261     Document Type: Article

References (25)

1. DiCenzo, R., Forrest, A., Slish, J. C. et al. (2003). A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy 23, 585-91.
2. Vervelde, M. L., Rademaker, C. M. A., Krediet, T. G. et al. (1999). Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen. Therapeutic Drug Monitoring 21, 514-19.
3. Hayani, K. C., Hatzopoulos, F. K., Fank, A. L. et al. (1997). Pharmacokinetics of once-daily dosing of gentamicin in neonates. Journal of Pediatrics 131, 76-80.
4. Rodvold, K. A., Gentry, C. A., Plank, G. S. et al. (1993). Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model. Developmental Pharmacology and Therapeutics 20, 211-19.
5. Stolk, L. M., Degraeuwe, P. L., Nieman, F. H. et al. (2002). Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Therapeutic Drug Monitoring 24, 527-31.
6. Agarwal, G., Rastogi, A., Pyati, S. et al. (2002). Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants ≥2500 g. Journal of Perinatology 22, 268-74.
7. Izquierdo, M., Lanao, J. M., Cervero, L. et al. (1992). Population pharmacokinetics of gentamicin in premature infants. Therapeutic Drug Monitoring 14, 177-83.
8. Davidian, M. & Giltinan, D. M. (1995). Monographs on Statistics and Applied Probability. Vol. 62. Nonlinear Models for Repeated Measurement Data, Chapman & Hall, London, UK.
9. Martin, E. S. (1991). The population pharmacokinetics of theophylline during the early postnatal period. Journal of Pharmacokinetics and Biopharmaceutics 19, Suppl, 59S-77S.
10. Vozeh, S., Maitre, P. O. & Stanski, D. R. (1990). Evaluation of population (NONMEM) pharmacokinetic parameter estimates. Journal of Pharmacokinetics and Biopharmaceutics 18, 161-73.
11. Jensen, P. D., Edgren, B. E. & Brundage, R. C. (1992). Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model. Pharmacotherapy 12, 178-82.
12. Botha, J. H., du Preez, M. J. & Adhikari, M (2003). Population pharmacokinetics of gentamicin in South African newborns. European Journal of Clinical Pharmacology 59, 755-9.
13. Thomson, A. H., Kokwaro, G. O., Muchohi, S. N. et al. (2003). Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya. British Journal of Clinical Pharmacology 56, 25-31.
14. Rocha, M. J., Almeida, A. M., Afonso, E. et al. (2000). The kinetic profile of gentamicin in premature neonates. Journal of Pharmacy and Pharmacology 52, 1091-7.
15. Ohler, K. H., Menke, J. A. & Fuller, F. (2000). Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit. American Journal of Perinatology 17, 285-90.
16. Faura, C. C., Garcia, M. R. & Horga, J. F. (1991). Changes in gentamicin serum levels and pharmacokinetic parameters in the newborn in the course of treatment with aminoglycoside. Therapeutic Drug Monitoring 13, 277-80.
17. Stickland, M. D., Kirkpatrick, C. M., Begg, E. J. et al. (2001). An extended interval dosing method for gentamicin in neonates. Journal of Antimicrobial Chemotherapy 48, 887-93.
18. Chattopadhyay, B. (2002). Newborns and gentamicin-how much and how often? Journal of Antimicrobial Chemotherapy 49, 13-6.
19. Miron, D. (2001). Once daily dosing of gentamicin in infants and children. Pediatric Infectious Disease Journal 20, 1169-73.
20. Skopnik, H., Wallraf, R., Nies, B. et al. (1992). Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Disease in Childhood 67, 57-61.
21. de Alba Romero, C., Castillo, E. G., Secades, C. M. at al. (1998). Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal 17, 1169-70.
22. Skopnik, H. & Heimann, G. (1995). Once daily aminoglycoside in full term neonates. Pediatric Infectious Disease Journal 14, 71-2.
23. Bass, K. D., Larkin, S. E., Paap, C. et al. (1998). Pharmacokinetics of once-daily gentamicin dosing in pediatric patients. Journal of Pediatrics Surgefy 33, 1104-7.
24. Carapetis, J. R., Jaquiery, A. L., Buttery, J. P. et al. (2001). Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatric Infectious Disease Journal 20, 240-6.
25. Nicolau, D. P., Freeman, C. D., Belliveau, P. P. et al. (1995). Experience with a once-daily aminoglycoside program administered to 2, 184 adult patients. Antimicrobial Agents and Chemotherapy 39, 650-5.